Yi Wen

ORCID: 0000-0003-0384-8747 · 11 papers in corpus · active 1998-2026

Study types

  • article 7
  • review 3
  • other 1

Condition tags

  • endometriosis 6
  • adenomyosis 5
  • dysmenorrhea 3
article 2026
·doi:10.31083/ceog48794

Background: Natural polyphenols are plant secondary metabolites with a broad spectrum of biological activities. Extensive preclinical studies have demonstrated the significant therapeutic efficacy of polyphenolic compounds in animal models …

review 2024
Archives of gynecology and obstetrics ·doi:10.1007/s00404-023-07340-x

OBJECTIVE: To analyze the efficacy of high-intensity focused ultrasound (HIFU) for adenomyosis and postoperative recurrence and its influencing factors. METHODS: Clinical and follow-up data of 308 patients with adenomyosis who were treated…

article 2024
Free radical biology & medicine ·doi:10.1016/j.freeradbiomed.2024.03.012

In various hyperproliferative disorders, damaged mitochondria can release mitochondrial DNA (mtDNA) into the cytoplasm, activating the cGAS-STING signaling pathway and subsequent immune imbalances. Our previous research has demonstrated tha…

article 2023
Cell journal ·doi:10.22074/cellj.2023.1989631.1230

OBJECTIVE: To investigate the effect of β-sitosterol on endometrial cells to understand the underlying mechanism. MATERIALS AND METHODS: This is a laboratory-based experimental study conducted on animals and cells. Histological assays were …

review 2022
Archives of gynecology and obstetrics ·doi:10.1007/s00404-022-06720-z
article 2022
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2022.2162495

BACKGROUND: NeiyiKangfu tablets (NYKF) are widely used clinically for the treatment of endometriosis (EMS), whose mechanism of action has been extensively studied. Researchers have found that NYKF may control the development of ectopic lesi…

review 2021
Frontiers in public health ·doi:10.3389/fpubh.2021.688264

Objective: High-intensity focused ultrasound (HIFU) is an innovative non-invasive technology used for adenomyosis. Gonadotropin-releasing hormone agonist (GnRH-a) is a hormone commonly used for adenomyosis. We investigated and assessed the …

other 2018
Chinese journal of integrative medicine ·doi:10.1007/s11655-017-2401-4

OBJECTIVE: To investigate the innate characters of 3 endometriosis (EMT) syndromes, blood stasis (BS), qi stagnation and blood stasis (QSBS) as well as Shen (Kidney) deficiency and blood stasis (KDBS) in terms of proteomics, lay a molecular…

article 2013

OBJECTIVE To make sure the expression differences of migration inhibitory factor(MIF)in endometriums and ectopic endometriums of patients with EMT of blood stasis and related main complication syndromes(blood stasis,blood stasis due to qi s…

article 2006
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition

OBJECTIVE: To investigate the expressions of matrix metalloproteinase -2, -3 (MMP-2,-3) and tissue inhibitor of metalloproteinase-2 (TIMP-2) in internal uterine endometriosis tissue and endometrium from women with and without endometriosis …

article 1998
·doi:10.1016/s1071-5576(97)86394-0